Testing LM11A-31 for progressive supranuclear palsy
Part of Brain & nervous system, Eyes & vision, Hormones & metabolism, Mental health clinical trials.
This trial tests a drug called LM11A-31 to see if it can help people with progressive supranuclear palsy (PSP), a rare brain condition. You may join if you have had symptoms for 5 years or less, can walk with minimal help, and have good thinking abilities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of possible or probable PSP Richardson's Syndrome (a common type of PSP).
- Your PSP symptoms started within the last 5 years.
- You score at least 25 on a memory and thinking test (MMSE).
- You can walk at least 10 steps with only a little help (like an arm for balance but not a walker).
- You live at home or in assisted living (not a nursing home).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaccine called AADvac1 for people with progressive supranuclear palsy (PSP), a brain condition that affects movement and thinking. The study wants to see if the vaccine can slow the disease down.
This study looks at genetic factors in people with PSP, CBS, MSA, or similar brain conditions, and also in their family members. It involves genetic testing to learn more about these diseases and may help find new treatments.
This trial tests potential new treatments for progressive supranuclear palsy (PSP), a brain disorder affecting movement, balance, and thinking. It aims to see if these treatments are safe and slow the disease. You may be able to join if you have a specific type of PSP and are in fairly good health.
This trial tests a new medicine called NIO752 for people with progressive supranuclear palsy (PSP), a condition that affects movement, balance, and thinking. The goal is to see if it can help slow the disease's progression.
This study tests a remote monitoring system to track symptoms of progressive supranuclear palsy (PSP) and similar movement disorders. It may tell you how your condition changes over time without needing frequent clinic visits.
This trial tests whether repeated non-invasive magnetic brain stimulation (TMS) can improve symptoms in people with progressive supranuclear palsy (PSP). It may help by targeting brain circuits involved in movement and balance.
Hear when a new PSP - Progressive Supranuclear Palsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.